1 / 44

Interferon-gamma and Interleukin 6 Modulate the Susceptibility of Macrophages to Human Immunodeficiency Virus Type 1 Inf

Interferon-gamma and Interleukin 6 Modulate the Susceptibility of Macrophages to Human Immunodeficiency Virus Type 1 Infection Zaitseva, M.; Lee, S.; Lapham, C.; Taffs, R.; King, L.; Romantseva, T.; Manischewitz, J.; and Golding, H. 2000. Blood: 96(9):3109-3117. Presented by: Alice Cioara.

atara
Download Presentation

Interferon-gamma and Interleukin 6 Modulate the Susceptibility of Macrophages to Human Immunodeficiency Virus Type 1 Inf

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Interferon-gamma and Interleukin 6 Modulate the Susceptibility of Macrophages to Human Immunodeficiency Virus Type 1 Infection Zaitseva, M.; Lee, S.; Lapham, C.; Taffs, R.; King, L.; Romantseva, T.; Manischewitz, J.; and Golding, H. 2000. Blood: 96(9):3109-3117. Presented by: Alice Cioara

  2. Cytokines • Important effector molecules • May exert multiple effects on viral entry and reverse transcription as well as reactivation • Proinflammatory cytokines • Interferon-gamma • Interleukin 6

  3. Interferon  • Maps to chromosome 12q24.1 • Is a dimeric protein • Interferon  (IFN- ) and receptor complexes are rapidly internalized by endocytosis • Has antiviral and antiparastic activities • Inhibits the proliferation of a number of normal and transformed cells

  4. Interferon  • A modulator of T-cell growth and functional differentiation • Regulates the expression of MHC class 2 genes • In macrophages – stimulates release of reactive oxygen species • Involved in processes of bone growth and inhibits bone resorption • Mediates host defense

  5. Interferon  • Is a potent activator of mononuclear phagocytes • Produced by: T and B cells, natural killer cells, and lymphocytes • Activated by antigens • Has both suppressive and enhancing effects

  6. Interleukin 6 • Maps to 7p21-p14 • Involved in T cell proliferation • Influences antigen-specific immune responses • Physiological stimuli for synthesis: • Bacterial endotoxins

  7. Interleukin 6 • Produced by: • Monocytes, fibroblasts and endothelial cells • After stimluation – also produced by: macrophages T-cells and B-lymphocytes • Limited to leukocyte subpopulations • Promotes inflammatory events • Serves a protective role

  8. Chemokines • Superfamily composed of 20 different leukocyte chemoattractants • Small proinflammatory proteins that recruit and activate leukocytes and inhibit the viral co-receptor function • Are chemotactic cytokines • 2 categories • CC (beta) • CXC (alpha)

  9. Chemokines • CC (beta) • Non-syncytium-inducing • Marcophagetropic variants use R5 viruses • Slow to replicate • Do not infect CD4+ T-cell lines • CXC (alpha) • Syncytium-inducing • T-cell line adapted use CXC chemokine receptor 4 (CXCR4)

  10. HIV • CC chemokine are fusion coreceptors for IV entry into macrophages • CCR5 – major determinant of entry • Macrophages are the main target and serve as a reservoir of HIV • Macrophages more efficiently infected by M-tropic HIV strains • Activation of Macrophages

  11. HIV • “The cytokine action created during the onset of an opportunistic infection or as a result of local inflammation may affect HIV infection of macrophages by providing a more favorable environment for emerging T-tropic viruses”

  12. IFN  AND Il-6 • To determine whether proinflammatory cytokines affect the ability of the macrophages to fuse with X4 envelope-expressing cells Procedure: • Macrophages were generated • Treated with cytokines (IFN , TNF, IL-6, and IL10) • Combined with cells expressing a T-tropic IIIB envelope

  13. IFN  AND Il-6 • Only IFN  & IL-6 exhibited enhancement in the numbers of syncytia • Monocyte-derived macrophages (MDM) obtained • Mixed (ratio 1:1) with X4 envelope-expressing target cells. • Quantified # of syncytia and analyzed

  14. IFN  AND Il-6

  15. Infection of MDMs with X4 • To see if there is a correlation between enhancement of X4 HIV-1 viral entry and an increase in fusion of cytokine-treated MDMs • Analysis of viral DNA at 48 hours using PCR was performed • MDM incubated with INF  or IL6 • Washed to remove cytokines • Infected with HIV-1(NL4-3) • DNA extracted after infection

  16. Infection of MDMs with X4

  17. Viral DNA in cytokine-treated MDMs • To determine if an increase in the primary production of treated viral DNA would increase viral reproduction: • 6-day MDMs incubated with cytokines • Washed and then infected with HIV(LAI)

  18. Viral DNA in cytokine-treated MDMs

  19. Viral DNA in cytokine-treated MDMs • Conclusion of Data: • IL-6 & INF  increase efficiency of X4-tropic viral entry, thus resulting in an increased production of infection of MDMs with T-tropic HIV-1

  20. Role of CXCR4 in IFN  and IL-6 • To determine the fusion of X4-tropic envelope with cytokine-treated MDMs was CXCR4 dependent:

  21. Role of CXCR4 in IFN  and IL-6 IL-6- and IFN- -induced increase in the fusion of macrophages with T-tropic envelope-expressing cells is CXCR4 dependent Experiment Cytokine Inhibitor #of syncytia with IIIB envelope 1 None None 5+1 IFN RANTES 45+8 2 None None 17+1 IFN  RANTES 72+9 3 None None 6+1 IL-6 RANTES 87+4 4 None None 1+1 IL-6 None 57+12

  22. Role of CXCR4 in IFN  and IL-6 • The previous data exhibits that CXCR4 does in fact participate in the fusion between X4-tropic envelopes with cytokine-treated macrophages

  23. Enhanced MDMs, X4-tropic and CXCR4 • Flow cytometry was done on the MDMs which were used in the fusion experiments to determine if there was a correlation between X4-tropic envelopes with enhanced MDMs and CXCR4 surface expression • 12 different experiments were conducted

  24. Enhanced MDMs, X4-tropic and CXCR4

  25. Enhanced MDMs, X4-tropic and CXCR4 • The previous data shows that the fusion between X4-tropic envelopes with the cytokine-treated MDMs does depend on CXCR4. • This fusion, however, is not due to an increase in the levels of surface CXCR4 expression.

  26. SDF-1-induced Ca++ flux • To determine if IFN  or IL-6 caused conformational changes in CXCR4 (in macrophages) which resulted in the improvement of ligand binding

  27. SDF-1-induced Ca++ flux • The previous data suggests that the fusion of X4-tropic envelope with the cytokine-treated MDMs does depend on CXCR4. • However, it is not ascribed to an increase in the level of CXCR4 expression

  28. Effect of Cx and H7 on IFN  and IL-6 • To determine if X4-tropic envelopes fusion with enhanced MDMs is linked with Stat1/3 activation: • MDMs pretreated with an inhibitor of Stat1/3 = H7 • These cells then mixed with IIIB envelope-expressing cells

  29. Effect of Cx and H7 on IFN  and IL-6 • H7 and cycloheximide inhibit IL-6- and IFN- -induced fusion of macrophages with T-tropic envelope-expressing cells Cytokine* Inhibitor No. of syncytia None None 7 ± 4 IL-6 None 72 ± 9 IL-6 Cx 6 ± 2 IL-6 H7 9 ± 1 None Cx 8 ± 4 None H7 3 ± 0 None None 14 ± 1 IFN None 61 ± 13 IFN Cx 13 ± 1 IFN H7 12 ± 2 None Cx 11 ± 1 None H7 9 ± 1

  30. IFN  and CCR5 • The reduction in the R5-tropic viral entry and reproduction detected in the presence of IFN  could be mediated by down-modulation of CD48 and/or the expression of CCR5 • Fusion assays • Surface staining • Performed 11 experiments+

  31. IFN  and CCR5

  32. IFN  and CCR5 • Treatment of MDM with IFN  • Slight reduction of surface CCR5 • Inhibition of MDMs with M-tropic envelopes = significant

  33. Effect of IL-6 and Macrophages • To determine if cytokines have the ability to change the susceptibility of macrophages to primary viral isolates

  34. Effect of IL-6 and Macrophages • The previous data shows that proinflammatory cytokines do have the ability to increase the susceptibility of macrophages to the infection with multiple primary X4 viruses

  35. Cytokine-treated MDMs secrete β-chemokine • To determine the mechanism liable for the effects of the fusion of MDMs with X4 and R5 envelope-expressing cells along with the cytokine treatment

  36. Cytokine-treated MDMs secrete β-Chemokines • IFN- and IL-6 induce chemokine production in macrophages Treatment* MIP-1 (pg/mL) MIP-1 (pg/mL) None 143 ± 35 66 ± 3 IFN- 909 ± 37 1425 ± 12 IL-6 647 ± 5 2176 ± 44

  37. Discussion • Exhibited: • IFN  and IL-6 exert a positive effect on the susceptibility of MDMs to infection with X4 HIV-1 • Induced an increase in X4 HIV-1 viral entry • Infection of MDMs • Promoted fusion of X4 and MDMs

  38. Discussion • Inhibitory effect • IFN  on R5 viral entry and the R5 reproduction of MDMs & fusion with target cells • β–chemokines were detected from IFN  & IL-6 treated MDMs.

More Related